Advertisement

Topics

Phil Erlanger Research Co., Inc. Company Profile

08:09 EST 23rd November 2017 | BioPortfolio

Welcome to Erlanger.com, a resource for investors seeking advanced technical analysis research and data. State-of-the-art computational techniques are combined with important, proprietary market data, enabling Phil Erlanger Research to offer independent, value-added data and analysis on over 6000 equity issues, 139 industry groups and 18 sectors. Following his experience as Advest 's Chief Technical Analyst, and his 5 year tenure as Senior Technical Analyst for Fidelity Management & Research Co. , Inc., Philip B. Erlanger formed his own company with the goal of providing high quality, unique information and research.

Location

Maynard
Massachusetts
United States of America


News Articles [54 Associated News Articles listed on BioPortfolio]

Phil Lands $10M to Expand End-to-End Prescription Delivery Service App

Phil, a San Francisco, CA-based end-to-end prescription management and delivery service connecting patients with local pharmacies has raised $10 million in funding led by Crosslink Capital. The round ...

US poker star Phil Ivey loses UK case, won't get millions

LONDON (AP) — He's long been a winner at cards, but American poker star Phil Ivey's good fortune does not extend to Britain's Supreme Court — he lost a major case Wednesday that will k...

Erlanger Agency Initiates Fundraiser To Help Fight Parkinson's Disease In Honor Of Loyal Customer, Juliana Frey.

Erlanger Agency, a full-service insurance provider serving the families of Central Ohio with an innovative community involvement program, initiates a new fundraising campaign in honor of Juliana Frey,...

Sinead O'Connor details abuse by her mother on 'Dr. Phil': 'She ran a torture chamber'

A bombshell interview between Dr. Phil and Sinead O'Connor is shedding light on the singer's lifelong battles with depression, suicide attempts and other severe mental issues that led to her...

Exxon Mobil-Aktie: antizyklische Investments sind möglich! - Aktienanalyse

New York - Exxon Mobil-Aktienanalyse von Analyst Phil Gresh von J.P. Morgan Securities: Phil Gresh, Aktienanalyst vom Investmenthaus J.P. Morgan Securities äußert im Rahmen einer aktuellen Aktienan....

Taking charge in U.S. flood zone, a rescuer inflates his record

By Emily Flitter HOUSTON (Reuters) - Phil Drager commanded a fleet of rescue boats, closed a highway, and flagged down a helicopter when he led efforts to rescue flood victims in Texas as waters rose...

Gilead Sciences-Aktie: vernünftige Bewertungen im Biotechsektor! - Aktienanalyse

New York - Gilead Sciences-Aktienanalyse von Analyst Phil Nadeau von Cowen and Company: Laut einer Aktienanalyse bestätigt Analyst Phil Nadeau vom Investmenthaus Cowen and Company seine Erwartung e.....

Gilead Sciences-Aktie ist klar unterbewertet! - Aktienanalyse

New York - Gilead Sciences-Aktienanalyse von Analyst Phil Nadeau von Cowen and Company: Laut einer Aktienanalyse bestätigt Analyst Phil Nadeau vom Investmenthaus Cowen and Company seine Erwartung e.....

PubMed Articles [758 Associated PubMed Articles listed on BioPortfolio]

Evaluation of a novel liquid embolic agent (precipitating hydrophobic injectable liquid (PHIL)) in an animal endovascular embolization model.

The choice of the embolic agent and the embolization technique can have a significant impact on the success of endovascular embolization.

Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.

A comparison is made of two contrast-enhanced ultrasound (CEUS) algorithms for the diagnosis of hepatocellular carcinoma (HCC) in high-risk patients: Erlanger Synopsis of Contrast-enhanced Ultrasound ...

Adding to the Truth of the Matter: The Case for Qualitative Research.

The purpose of this column is to discuss the impact that qualitative research has on translational research, whose aim is to improve the health and well-being of individuals. To that end, rigorous qua...

Collaborative Orthopaedic Research Between and Within Institutions.

Collaborative research is common in many medical disciplines; however, the field of orthopaedics has been relatively slow to adopt this type of research approach. Collaborative research efforts can oc...

Research Ethics 2.0: New Perspectives on Norms, Values, and Integrity in Genomic Research in Times of Even Scarcer Resources.

Research ethics anew gained importance due to the changing scientific landscape and increasing demands and competition in the academic field. These changes are further exaggerated because of scarce(r)...

Clinical Trials [950 Associated Clinical Trials listed on BioPortfolio]

PHIL Evaluation in the Endovascular Treatment of Intracranial Cerebral ArterioVenous Malformation (cAVM)

The primary objective of this study is to assess the efficacy and safety of PHIL® liquid embolic agent in endovascular embolization of cerebral arteriovenous malformations.

PHIL Evaluation in the Endovascular Treatment of Intracranial Dural AVF

The primary objective of this study is to demonstrate the safety and efficacy of the PHIL® liquid in endovascular treatment of dural arteriovenous fistula.

Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer

Ovarian cancer may be caused by a build-up of genetic defects, or damaged genes within the cells of the body. Because the genes are damaged, the body is unable to produce a group of protei...

Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer

Ovarian cancer may be caused by a build-up of genetic defects, or damaged genes within the body's cells. When genes are damaged, the body may be unable to produce a group of proteins, call...

Research Participants' Views on the Ethics of Clinical Research

This pilot study will explore the usefulness of a series of questions asking about views of research from the perspective of minority and economically disadvantaged research participants. ...

Companies [1009 Associated Companies listed on BioPortfolio]

Phil Erlanger Research Co., Inc.

Welcome to Erlanger.com, a resource for investors seeking advanced technical analysis research and data. State-of-the-art computational techniques are combined with important, proprietary market data,...

Purple Heart Injury Laboratories

PHIL is a Defense Medicine™ incubator that supports the development of new technologies and therapies for healing battlefield injuries. PHIL’s objective is to become the...

Phil Inc.

Phil is an end-to-end prescription management service providing a convenient alternative to traditional pharmaceutical management. Through its desktop website and mobile app, Phil...

Phil Ellis Associates, Inc.

Phil Ellis Associates, Inc. is a professional search and recruiting firm specializing in the pharmaceutical, medical device, diagnostic, biomedical and allied industries and operates under the guidanc...

ValueMedics Research, LLC

Jonothan C. Tierce, C.Phil., and Elisabeth H. Hazard, Ph.D., formed ValueMedics in 2003. The initial staff was made up of the Health Economics, Outcomes Research, Pricing and Market Access unit of the...

More Information about "Phil Erlanger Research Co., Inc." on BioPortfolio

We have published hundreds of Phil Erlanger Research Co., Inc. news stories on BioPortfolio along with dozens of Phil Erlanger Research Co., Inc. Clinical Trials and PubMed Articles about Phil Erlanger Research Co., Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phil Erlanger Research Co., Inc. Companies in our database. You can also find out about relevant Phil Erlanger Research Co., Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record